Last reviewed · How we verify
NCT05220683
Digital Marking Systems
NA trial testing digital marking system in Cataract in 15 participants. Status unknown.
1 July 2023
Quick facts
| Lead sponsor | Vienna Institute for Research in Ocular Surgery |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 15 |
| Start date | 1 July 2021 |
| Primary completion | 1 July 2023 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- digital marking system
Conditions studied
- Cataract — all drugs for Cataract →
Sponsor
Vienna Institute for Research in Ocular Surgery
Who can join
Adults 21 to 105, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison of the alignment axis of the Alcon Verion and the Zeiss Callisto alignment systems intraoperatively
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of two digital alignment systems for toric intraocular lens implantation.
Zeilinger J, Schlatter A, Ruiss M, Bayer N, et al · · 2024 · PMID 39284678 · DOI 10.1136/bmjophth-2024-001875
Verify or expand the search:
- PubMed search for NCT05220683
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Vienna Institute for Research in Ocular Surgery trials
Trials by the same sponsor.
- NCT07262021 — Visual Function of Enhanced Monofocal Intraocular Lenses · NA · not yet recruiting
- NCT06914817 — Brillouin Microscopy Used to Evaluate Corneal Mechanical Properties · NA · not yet recruiting
- NCT07297849 — Eyelid Closure in Keratometry · NA · recruiting
- NCT07390253 — Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration · active not recruiting
- NCT06607848 — Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05220683 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vienna Institute for Research in Ocular Surgery
- Last refreshed: 2 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05220683.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing